State of the Therapeutics landscape in Q1 2025
In this second update of 2025, we outline the investment landscape and activity in Therapeutics over Q1. We discuss deal volume, with most deals in seed and start-up stages, the shift in median deal sizes and the deal frequency per therapeutic area. We also highlight two interesting deals made in the past three months.
